- February 2018: Neuro-Zone appoints Dr. Noemi Tonna as Chief Scientific Officer.
Neuro-Zone offers relevant multiparametric analysis of complex intercellular cross-talk mechanisms for drug discovery projects in the areas of inflammation and ageing-related diseases.
The company aims to create a scientific interconnection with its partners, understanding their biological needs and providing customized solutions, from project layout to operative experimental execution and data analysis.
With a deep cell-based background, several functional pathology-specific platforms and a smart technological approach, Neuro-Zone provides preclinical research supports with a peculiar focus on the analysis of the microenvironment.
a brief review of our main successes
September 2017: Neuro-Zone invests in Bio4Dreams, the first privately owned Business Accelerator in Life Sciences (Bio4Dreams).
In October 2013: Neuro-Zone is among the sponsors of the Italian Neuroscience Sociaty Meeting (SINS).
In May 2012: Neuro-Zone is selected by the Italian Government to be among the “Italy for Innovators” companies at the EXPO 2012 in Korea.
In January 2010: Neuro-Zone is among the finalists of the European Academic Enterprise Award.